Insider · CIK 0001229765

GRIFFIN MICHELLE RENEE

Reports to the SEC for 9 companies · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001229765

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-25	ADPTAdaptive Biotechnologies CorpS Sale	Director	SSale	−52.1K sh	$20.18	−$1.05M	15,625
2026-06-25	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−52.1K sh	—	—	0
2026-06-25	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Director	MExercise/Conversion	+52.1K sh	$7.80	+$406K	67,709
2026-03-11	ADPTAdaptive Biotechnologies CorpS Sale	Director	SSale	−15.4K sh	$13.91	−$214K	15,625
2026-03-04	ADPTAdaptive Biotechnologies CorpA Award	Director	AAward	+15.6K sh	—	—	31,019
2026-03-03	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Director	MExercise/Conversion	+48K sh	$3.99	+$192K	63,438
2026-03-03	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−48K sh	—	—	0
2026-03-03	ADPTAdaptive Biotechnologies CorpS Sale	Director	SSale	−48K sh	$15.30	−$735K	15,394
2025-03-13	ADPTAdaptive Biotechnologies CorpS Sale	Director	SSale	−36.3K sh	$7.19	−$261K	15,394
2025-03-06	ADPTAdaptive Biotechnologies CorpS Sale	Director	SSale	−15.7K sh	$7.94	−$124K	51,685
2025-03-04	ADPTAdaptive Biotechnologies CorpA Award	Director	AAward	+15.4K sh	—	—	67,349
2025-03-04	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)A Award	Director	AAward	+23.7K sh	—	—	23,726
2024-03-04	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)A Award	Director	AAward	+48K sh	—	—	48,044
2024-03-04	ADPTAdaptive Biotechnologies CorpA Award	Director	AAward	+31.3K sh	—	—	51,955
2023-08-11	CHINOOK THERAPEUTICS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−3,300 sh	—	—	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.3K sh	$26.12	−$347K	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−23.5K sh	$25.23	−$593K	0
2023-08-11	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,948 sh	$23.19	−$138K	0
2023-05-26	CHINOOK THERAPEUTICS, INC.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,300 sh	—	—	0
2023-05-26	CHINOOK THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,300 sh	—	—	3,300
2023-03-27	ADPTAdaptive Biotechnologies CorpS Sale	Director	SSale	−2,341 sh	$8.49	−$19.9K	20,627
2023-03-14	Acer Therapeutics Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2023-03-06	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)A Award	Director	AAward	+23.3K sh	—	—	23,329
2023-03-06	ADPTAdaptive Biotechnologies CorpA Award	Director	AAward	+14.8K sh	—	—	22,968
2022-09-15	HTG MOLECULAR DIAGNOSTICS, INCStock Option (right to buy)A Award	Director	AAward	+4,000 sh	—	—	4,000
2022-05-26	CHINOOK THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+13.3K sh	—	—	13,300
2022-05-26	CHINOOK THERAPEUTICS, INC.Restricted Stock UnitA Award	Director	AAward	+3,300 sh	—	—	3,300
2022-01-26	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)A Award	Director	AAward	+16.7K sh	—	—	16,722
2022-01-26	ADPTAdaptive Biotechnologies CorpA Award	Director	AAward	+6,689 sh	—	—	8,193
2022-01-14	Acer Therapeutics Inc.Stock Option (right to buy)A Award	Director	AAward	+18.5K sh	—	—	18,500
2021-08-27	ADPTAdaptive Biotechnologies CorpS Sale	Director	SSale	−14.9K sh	$35.00	−$522K	1,504
2021-08-27	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−14.9K sh	—	—	52,084
2021-08-27	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Director	MExercise/Conversion	+14.9K sh	$7.80	+$116K	16,420
2021-08-18	HTG MOLECULAR DIAGNOSTICS, INCStock Option (right to buy)A Award	Director	AAward	+4,000 sh	—	—	4,000
2021-07-14	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	67,000
2021-07-14	ADPTAdaptive Biotechnologies CorpS Sale	Director	SSale	−2,500 sh	$36.80	−$92K	1,504
2021-07-14	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$7.80	+$19.5K	4,004
2021-06-17	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	69,500
2021-06-17	ADPTAdaptive Biotechnologies CorpS Sale	Director	SSale	−4,000 sh	$40.00	−$160K	1,504
2021-06-17	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	$7.80	+$31.2K	5,504
2021-06-14	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	73,500
2021-06-14	ADPTAdaptive Biotechnologies CorpS Sale	Director	SSale	−2,500 sh	$38.56	−$96.4K	1,504
2021-06-14	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$7.80	+$19.5K	4,004
2021-06-04	CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+5,948 sh	—	—	5,948
2021-05-18	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	$7.80	+$19.5K	4,004
2021-05-18	ADPTAdaptive Biotechnologies CorpS Sale	Director	SSale	−2,500 sh	$35.00	−$87.5K	1,504
2021-05-18	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	76,000
2021-04-14	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,500 sh	—	—	78,500
2021-04-14	ADPTAdaptive Biotechnologies CorpS Sale	Director	SSale	−4,500 sh	$43.41	−$195K	1,504
2021-04-14	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Director	MExercise/Conversion	+4,500 sh	$7.80	+$35.1K	6,004

Recent filings

Accepted (ET)
Jun 294
GRIFFIN MICHELLE RENEE0001229765-26-000008
SEC(opens sec.gov)
Mar 134
GRIFFIN MICHELLE RENEE0001229765-26-000006
SEC(opens sec.gov)
Mar 64
GRIFFIN MICHELLE RENEE0001229765-26-000004
SEC(opens sec.gov)
Mar 54
GRIFFIN MICHELLE RENEE0001229765-26-000001
SEC(opens sec.gov)
Mar 174
GRIFFIN MICHELLE RENEE0001062993-25-005644
SEC(opens sec.gov)
Mar 64
GRIFFIN MICHELLE RENEE0001062993-25-004800
SEC(opens sec.gov)
Mar 64
GRIFFIN MICHELLE RENEE0001062993-24-005770
SEC(opens sec.gov)
Aug 114
GRIFFIN MICHELLE RENEE0001209191-23-045422
SEC(opens sec.gov)
May 314
GRIFFIN MICHELLE RENEE0001209191-23-033188
SEC(opens sec.gov)

Companies

Address

C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1165 EASTLAKE AVENUE EAST

SEATTLE, WA, 98109